Company
cAMPfield Therapeutics
Redefining the Treatment of Inflammatory Diseases
Also known as cAMPfield Therapeutics, Inc.
- Business model
- B2B
- Headquarters
- San Diego, CA, United States
- Legal name
- cAMPfield Therapeutics, Inc.
- campfieldtx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
cAMPfield Therapeutics is a biopharma company developing well-tolerated and highly effective oral medicines for immune-mediated inflammatory diseases, including IBD.
Funding snapshot
- Total raised
- $180MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series A, $180M2026-06-18
Funding rounds
- Series A
- $180M2026-06-18, Company stated
Products
- Other
- prifemilast
- Web
- prifemilast
Loading relationship preview